[
  {
    "objectID": "research.html",
    "href": "research.html",
    "title": "Research",
    "section": "",
    "text": "My research involves the development of Bayesian methods for the design and analysis of clinical trials. In particular, I have an interest in robust informative prior elicitation using historical data and/or expert opinion. I also have interests in subgroup estimation and identification.\nBelow is a list of my published papers (listed chronologically by publication/acceptance date) as well as manuscripts submitted to journals. For works in progress, please refer to my CV."
  },
  {
    "objectID": "research.html#published-and-accepted-works",
    "href": "research.html#published-and-accepted-works",
    "title": "Research",
    "section": "Published and Accepted Works",
    "text": "Published and Accepted Works\n\nStatistical Methodology\n\nEthan M. Alt, Matthew A. Psioda, and Joseph G. Ibrahim. “A Bayesian approach to study design and analysis with type I error rate control for response variables of mixed types.” Statistics in Medicine 42, no. 11 (2023): 1722-1740. https://doi.org/10.1002/sim.9696.\n\n\nEthan M. Alt, Brady Nifong, Xinxin Chen, Matthew A. Psioda, and Joseph G. Ibrahim. “The scale transformed power prior for use with historical data from a different outcome model.” Statistics in Medicine 42, no. 1 (2023): 1-14. https://doi.org/10.1002/sim.9598.\n\n\nEthan M. Alt, Matthew A. Psioda, and Joseph G. Ibrahim. “Bayesian multivariate probability of success using historical data with type I error rate control.” Biostatistics 24, no. 1 (2023): 17-31. https://doi.org/10.1093/biostatistics/kxab050.\n\n\nEthan M. Alt, Matthew A. Psioda, and Joseph G. Ibrahim. “A hierarchical prior for generalized linear models based on predictions for the mean response.” Biostatistics 23, no. 4 (2022): 1165-1181. https://doi.org/10.1093/biostatistics/kxac022.\n\n\n\nCollaborative Work\n\nElvira D’Andrea, Deborah J. Wexler, Seoyoung C. Kim, Julie M. Paik, Ethan Alt, and Elisabetta Patorno. “Comparing Effectiveness and Safety of SGLT2 Inhibitors vs DPP-4 Inhibitors in Patients With Type 2 Diabetes and Varying Baseline HbA1c Levels.” JAMA Intern Med. 183, no. 3 (2023): 242–254 (2023). https://doi.org/10.1001/jamainternmed.2022.6664.\n\n\nPhyo T. Hoo, Julie M. Paik, Ethan Alt, Dae Hyun Kim, Deborah J. Wexler, Seoyoung C. Kim, and Elisabetta Patorno. “Risk of severe hypoglycemia with newer second-line glucose-lowering medications in older adults with type 2 diabetes stratified by known indicators of hypoglycemia risk.” The Journals of Gerontology: Series A (In Press). https://doi.org/10.1093/gerona/glad075.\n\n\nAllison J. Burbank, Anusha Vadlamudi, Katherine H. Mills, Ethan M. Alt, Heather Wells, Haibo Zhou, Neil Alexis, Michelle L. Hernandez, and David B. Peden. “The glutathione-S-transferase mu-1 null genotype increases wood smoke-induced airway inflammation.” Journal of Allergy and Clinical Immunology 143, no. 6 (2019): 2299-2302. https://doi.org/10.1016/j.jaci.2019.02.006.\n\n\nAllison J. Burbank, Michelle L. Hernandez, Katherine H. Mills, Neil Alexis, Ethan M. Alt, Haibo Zhou, and David B. Peden. “Characterizing Airway Inflammatory Responses to Wood-Smoke Inhalation.” Journal of Allergy and Clinical Immunology 143, no. 2 (2019): https://doi.org/10.1016/j.jaci.2018.12.073."
  },
  {
    "objectID": "research.html#works-under-review-or-in-revision",
    "href": "research.html#works-under-review-or-in-revision",
    "title": "Research",
    "section": "Works Under Review or In Revision",
    "text": "Works Under Review or In Revision\n\nStatistical Methodology\n\nEthan M. Alt, Xiuya Chang, Xun Jiang, Qing Liu, May Mo, H. Amy Xia, and Joseph G. Ibrahim. “LEAP: The latent exchangeability prior for borrowing information from historical data.” Journal of the American Statistical Association. (Under review).\n\n\nEthan M. Alt, Brady Nifong, Xinxin Chen, Matthew A. Psioda, and Joseph G. Ibrahim. “The scale transformed power prior for time-to-event data.” Lifetime Data Analysis. (In revision).\n\n\nXiaming Tan, William Wang, Donglin Zeng, Guanghan Liu, Guoqing Diao, Niusha Jafari, Ethan Alt Joseph Ibrahim. “Safety signal detection with control of latent factors.” Statistics in Medicine. (Under review).\n\n\n\nCollaborative Work\n\nHoJin Shin, Shirley V. Wang, Dae Hyun Kim, Ethan Alt, Mufaddal Mahesri, Lily G. Bessette, Sebastian Schneeweiss, and Mehdi Najafzadeh. “Predicting treatment effects of a new-to-market drug in clinical practice based on phase III randomized trial results.” Clinical Pharmacology and Therapeutics. (Under review).\n\nYanmin Zhu, Sonia Hernandez-Diaz, Brian T. Bateman, Kathryn J. Gray, Ethan Alt, Loreen Straub, Lockwood G Taylor, Rita Ouellet-Hellstrom, Yong Ma, Yandong Qiang, Seanna Vine, Helen Mogun, Wei Hua, Krista F. Huybrechts. “Development and validation of claims-based algorithms for estimating gestational age of spontaneous abortion and termination.”"
  },
  {
    "objectID": "talks.html",
    "href": "talks.html",
    "title": "Talks and Presentations",
    "section": "",
    "text": "Below is a list of the talks I have given, along with links to the corresponding presentation. All talks were presented by myself unless otherwise noted."
  },
  {
    "objectID": "talks.html#invited-presentations",
    "href": "talks.html#invited-presentations",
    "title": "Talks and Presentations",
    "section": "Invited Presentations",
    "text": "Invited Presentations\n\nLEAP: The latent exchangeability prior for the incorporation of historical data | BayesPharma 2023 | Utrecht, Netherlands\nLEAP: The latent exchangeability prior for control arm augmentation | JSM 2023 | Toronto, Canada\nLEAP: The latent exchangeability prior for control arm augmentation | IISA 2023 | Golden, Colorado\nLEAP: The latent exchangeability prior for control arm augmentation | ENAR 2023 | Nashville, Tennessee\nA hierarchical prior for generalized linear models based on predictions for the mean response | JSM 2022 (Presented by Dr. Matthew Psioda) | Washington, DC\nNormalized Power Priors in Stan| Stan-Dev 2022 | Online\nMultivariate probability of success for rare diseases | ASA Biopharmaceutical Section Regulatory Industry Statistics Workshop | Online"
  },
  {
    "objectID": "talks.html#contributed-presentations",
    "href": "talks.html#contributed-presentations",
    "title": "Talks and Presentations",
    "section": "Contributed Presentations",
    "text": "Contributed Presentations\n\nDesign and analysis of clinical trials with mixed outcome types | ENAR 2022 | Houston, Texas\nBayesian multivariate probability of success with type 1 error control | JSM 2021 | Online\nBayesian probability of success for multivariate normal endpoints using historical data | ENAR 2021 | Online"
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "Dr. Ethan Alt’s Personal Website",
    "section": "",
    "text": "Welcome!\nWelcome to my personal website! Currently, I am an Assistant Professor in the Department of Biostatistics at the University of North Carolina at Chapel Hill.\nPreviously, I was Instructor of Medicine in the Divisision of Pharmacoepidemiology and Pharmacoeconomics at Harvard Medical School.\n\n\nDepartmental Profile\nMy departmental profile is available here, but this website will contain the most up-to-date information.\n\n\nAbout this website\nOn this website, you can find my CV, software, and presentations. I may eventually add a blog."
  },
  {
    "objectID": "about.html",
    "href": "about.html",
    "title": "Ethan Alt",
    "section": "",
    "text": "Dr. Ethan Alt is an Assistant Professor in the Department of Biostatistics at the University of North Carolina at Chapel Hill. His research interests include the development of Bayesian methods for clinical trials, informative prior elicitation, and Bayesian nonparametrics.\nDr. Alt received a PhD in Biostatistics from the University of North Carolina at Chapel Hill in 2021. His dissertation was supervised by Drs. Matthew Psioda and Joseph Ibrahim."
  },
  {
    "objectID": "about.html#education",
    "href": "about.html#education",
    "title": "Ethan Alt",
    "section": "Education",
    "text": "Education\nUniversity of North Carolina | Chapel Hill, NC\nPhD, Biostatistics | Aug 2017 - Sep 2021\nUniversity of Florida | Gainesville, FL\nMS, Statistics | Aug 2015 - May 2017"
  },
  {
    "objectID": "about.html#experience",
    "href": "about.html#experience",
    "title": "Ethan Alt",
    "section": "Experience",
    "text": "Experience\nUniversity of North Carolina | Research Assistant Professor | Oct 2022 - present\nHarvard Medical School | Instructor of Medicine | Oct 2021 - Oct 2022"
  },
  {
    "objectID": "software.html",
    "href": "software.html",
    "title": "Software",
    "section": "",
    "text": "Below is a list of software I have developed / am in the process of developing. For more information, check out my GitHub page.\n\nhdbayes\nhdbayes is a package that utilizes Stan to conduct informative prior elicitation on the basis of historical data. Current implementations are for generalized linear models (GLMs) and include the power prior, Bayesian hierarchical model, robust meta-analytic prior, and commensurate prior. It is currently only available on GitHub.\n\n\nbmabasket\nbmabasket is an R package designed to assist researchers in designing and analyzing basket trials according to the method of Psioda and others (2019). It is available on CRAN."
  }
]